425: Aegon Reports Stable H1 2026 Results Amid US Relocation

Aegon Ltd. announced stable net results and increased operating results for the first half of 2026, driven by strong commercial growth in Transamerica and progress on its strategic relocation to the US.

Summary

• Aegon Ltd. reported a net result of EUR 608 million for the first half of 2026, stable compared to the prior year period.
• Operating result increased by 9% to EUR 804 million, and operating capital generation grew by 27% to EUR 416 million.
• Free cash flow was EUR 392 million.
• The company announced an interim dividend of EUR 0.21 per share, an 11% increase year-over-year.
• A share buyback program was increased by EUR 150 million to EUR 350 million.
• Significant progress was made on the planned relocation to the US, including selecting New York City as the future head office location.
• The sale of Aegon UK to Standard Life for GBP 2.0 billion is expected to close around the end of 2026.
• An Extraordinary General Meeting is targeted for October 8, 2026, to approve the redomiciliation to the US.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive filing, reflecting solid operational performance and strategic progress, particularly with the US relocation, though some financial metrics show slight declines or remain stable.

Positives

• Transamerica experienced strong commercial growth, with Individual Life sales up 54% and annuity sales up 12%.
• World Financial Group (WFG) expanded its agent network to over 100,000 agents.
• Operating result increased by 9% to EUR 804 million.
• Operating capital generation grew by 27% to EUR 416 million.
• Free cash flow generation was robust at EUR 392 million.
• Interim dividend increased by 11% to EUR 0.21 per share.
• Share buyback program increased by EUR 150 million to EUR 350 million.
• The sale of Aegon UK for GBP 2.0 billion is progressing, with expected closure by year-end 2026.

Negatives

• Retirement Plans gross deposits decreased by 7% due to a large pooled plan deposit in the prior year and a contract termination following a merger.
• Net outflows in Variable Annuities were 11% higher than the prior year period.
• Shareholders equity decreased by 1% to EUR 7.3 billion.
• Contractual Service Margin (CSM) decreased by 14% to EUR 6.9 billion.
• The Group solvency ratio decreased to 169% from 184% due to loss of capital eligibility for certain bonds and planned capital distributions.

Risks

• The sale of Aegon UK is subject to customary conditions, including regulatory approvals.
• The redomiciliation to the US is subject to shareholder approval at the Extraordinary General Meeting.
• Changes in policyholder behavior observed in recent periods led to adjustments in the annual assumptions review.
• Potential for unfavorable market movements impacting financial assets and solvency ratios.
• Risks associated with the implementation of US GAAP for full-year 2027 results.
• The company faces ongoing risks related to economic conditions, financial markets, regulatory changes, and competition as detailed in the disclaimer.

Future Outlook

Aegon aims to grow its operating result by around 5% per year over the 2026-2027 period and free cash flow by around 5% per annum (excluding remittances from Aegon UK or dividends from Standard Life). Dividend per share is expected to grow in excess of 5% per annum. The company is on track to meet or exceed its Group financial ambitions for 2026.

Management Comments

• In the first half of 2026, we continued to grow our businesses, delivered robust financial results and progressed at pace with our planned relocation to the US.
• These results demonstrate our strategy is gaining momentum and reinforce our confidence in the ambitions outlined at our 2025 Capital Markets Day.
• We made significant progress in preparing for our future in the US.
• Our businesses are well capitalized and we are on track to meet or exceed our Group financial ambitions for 2026.

Industry Context

StockSavvy.ai notes that Aegon's strategic shift towards the US market, including its planned redomiciliation and the sale of its UK operations, aligns with broader trends of consolidation and geographic focus within the global insurance and retirement services sector. The company's performance in key segments like Transamerica's life insurance and retirement plans reflects competitive pressures and opportunities in the North American market.

Comparison to Industry Standards

• Transamerica's Individual Life sales growth of 54% in H1 2026 significantly outpaces general industry growth rates for life insurance products, which are typically in the low single digits.
• The increase in WFG agents to over 100,000 indicates a strong focus on agency distribution, a common strategy in the US life insurance market, though agent productivity and retention are key performance indicators.
• The Group solvency ratio of 169% is above the typical regulatory minimums (e.g., Solvency II minimums often around 100-150%), indicating a strong capital position, though it has decreased from the previous period.
• The interim dividend increase of 11% and the increased share buyback program suggest confidence in future earnings and capital generation, aligning with practices of mature financial institutions seeking to return capital to shareholders.

Management Changes

Corporate Governance

Legal Proceedings

• Preliminary settlement approval granted in a class action alleging improper failure to pay bonuses on certain universal life policies (fully provisioned).
• Preliminary settlement approval granted in litigation regarding increases in monthly deduction rates on universal life products (settlement paid, provision released).

Related Party Transactions

• Agreement with Vereniging Aegon (largest shareholder) on future relationship and US-aligned governance framework.
• Vereniging Aegon participated in share buybacks.

Stakeholder Impact

• Shareholders: Increased interim dividend and expanded share buyback program signal commitment to returning capital.
• Employees: Leadership continuity and planned US relocation may impact roles and organizational structure.
• Regulators: Ongoing compliance with Bermuda, US, and other jurisdictional solvency and reporting requirements.
• Customers: Continued focus on product development and service, with adjustments to assumptions impacting contract valuations.

Next Steps

• Seek shareholder approval for the redomiciliation to the US at the Extraordinary General Meeting on October 8, 2026.
• Complete the sale of Aegon UK to Standard Life around the end of 2026.
• Implement US GAAP on track for a first release of full-year 2027 results.
• Continue execution of the EUR 350 million share buyback program, expected to be completed by December 23, 2026.
• Continue progress on the relocation of the head office and legal seat to the US.

Key Dates

Recommendation

The company is executing a significant strategic transformation with the US relocation and sale of UK operations. While operational performance is stable to positive, the financial results show some areas of decline or pressure, and the full impact of the US transition is yet to be realized. The increased dividend and buyback are positive, but the overall picture warrants a cautious 'hold' stance until the strategic shift demonstrates more concrete financial benefits and integration success.

Keywords

Aegon, Interim Financial Information, Transamerica, US Relocation, Aegon UK Sale, Operating Result, Share Buyback, Dividend